Aerovate Therapeutics

YTD

ALL

Why Robinhood?

You can watch AVTE and buy or sell other stocks, ETFs, and their options commission-free!

About AVTE

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.

CEO

Tom Frohlich, MBA

CEOTom Frohlich, MBA

Employees

Employees30

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2018

Founded2018

Employees

Employees30

AVTE Key Statistics

Market cap

8.12M

Market cap8.12M

Price-Earnings ratio

-0.18

Price-Earnings ratio-0.18

Dividend yield

—

Dividend yield—

Average volume

706.08K

Average volume706.08K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$105.00

52 Week high$105.00

52 Week low

$6.57

52 Week low$6.57

People also own

Based on the portfolios of people who own AVTE. This list is generated using Robinhood data, and it’s not a recommendation.